Хайлтын үр дүнгүүд - Maloney, David G
- 137-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
-
2
Rituximab Resistance -н Rezvani, Andrew R., Maloney, David G.
Хэвлэсэн 2011текст -
3
-
4
-
5
-
6
Health State Utilities for Adverse Events Associated with Chimeric Antigen Receptor T-Cell Therapy in Large B-Cell Lymphoma -н Howell, Timothy A., Matza, Louis S., Jun, Monika P., Garcia, Jacob, Powers, Annette, Maloney, David G.
Хэвлэсэн 2022текст -
7
-
8
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia -н Sorror, Mohamed L., Storer, Barry E., Maloney, David G., Sandmaier, Brenda M., Martin, Paul J., Storb, Rainer
Хэвлэсэн 2008текст -
9
The Impact of Donor Type and ABO Incompatibility on Transfusion Requirements after Nonmyeloablative Hematopoietic Cell Transplantation (HCT) -н Wang, Zejing, Sorror, Mohamed L., Leisenring, Wendy, Schoch, Gary, Maloney, David G., Sandmaier, Brenda M., Storb, Rainer
Хэвлэсэн 2010текст -
10
-
11
Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Concurrent Lymphoid Malignancy -н Zimmerman, Zachary, Scott, Bart L., Gopal, Ajay K., Sandmaier, Brenda M., Maloney, David G., Deeg, H. Joachim
Хэвлэсэн 2011текст -
12
A phase 3 randomized study (HOMER) of ofatumumab vs rituximab in iNHL relapsed after rituximab-containing therapy -н Maloney, David G., Ogura, Michinori, Fukuhara, Noriko, Davis, Jaclyn, Lasher, Janet, Izquierdo, Miguel, Banerjee, Hiya, Tobinai, Kensei
Хэвлэсэн 2020текст -
13
Effect of lisocabtagene maraleucel on HRQoL and symptom severity in relapsed/refractory large B-cell lymphoma -н Patrick, Donald L., Powers, Annette, Jun, Monika Parisi, Kim, Yeonhee, Garcia, Jacob, Dehner, Christine, Maloney, David G.
Хэвлэсэн 2021текст -
14
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT -н Sorror, Mohamed L., Maris, Michael B., Storb, Rainer, Baron, Frederic, Sandmaier, Brenda M., Maloney, David G., Storer, Barry
Хэвлэсэн 2005текст -
15
Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs -н Nakamae, Hirohisa, Storer, Barry, Sandmaier, Brenda M., Maloney, David G., Davis, Chris, Corey, Lawrence, Storb, Rainer, Boeckh, Michael
Хэвлэсэн 2011текст -
16
Allogeneic Hematopoietic Cell Transplant for Patients with End Stage Renal Disease Requiring Dialysis – a Single Institution Experience -н Shadman, Mazyar, Hingorani, Sangeeta, Lanum, Scott A., Pagel, John M., Storb, Rainer, Maloney, David G., Sandmaier, Brenda M.
Хэвлэсэн 2016текст -
17
-
18
Impact of Rituximab and Host/Donor Fc Receptor Polymorphisms after Allogeneic Hematopoietic Cell Transplantation for CD20(+) B Cell Malignancies -н Granot, Noa, Rezvani, Andrew R., Pender, Barbara S., Storer, Barry E., Sandmaier, Brenda M., Storb, Rainer, Maloney, David G.
Хэвлэсэн 2020текст -
19
Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapy -н Chow, Victor A., Gopal, Ajay K., Gauthier, Jordan, Tseng, Yolanda D., Turtle, Cameron J., Maloney, David G., Shadman, Mazyar
Хэвлэсэн 2020текст -
20